174 related articles for article (PubMed ID: 32387041)
1. COVID-19 and Moral Imperialism in Multinational Clinical Research.
Hellmann F; Williams-Jones B; Garrafa V
Arch Med Res; 2020 Aug; 51(6):572-573. PubMed ID: 32387041
[TBL] [Abstract][Full Text] [Related]
2. Covid-19 Vaccine Trials and Incarcerated People - The Ethics of Inclusion.
Strassle C; Jardas E; Ochoa J; Berkman BE; Danis M; Rid A; Taylor HA
N Engl J Med; 2020 Nov; 383(20):1897-1899. PubMed ID: 33085884
[No Abstract] [Full Text] [Related]
3. COVID-19 vaccine development pipeline gears up.
Mullard A
Lancet; 2020 Jun; 395(10239):1751-1752. PubMed ID: 32505245
[No Abstract] [Full Text] [Related]
4. Ethical guidelines for deliberately infecting volunteers with COVID-19.
Richards AD
J Med Ethics; 2020 Aug; 46(8):502-504. PubMed ID: 32461245
[TBL] [Abstract][Full Text] [Related]
5. Why Challenge Trials of SARS-CoV-2 Vaccines Could Be Ethical Despite Risk of Severe Adverse Events.
Eyal N
Ethics Hum Res; 2020 Jul; 42(4):24-34. PubMed ID: 32441894
[TBL] [Abstract][Full Text] [Related]
6. COVID-19: endgames.
The Lancet Infectious Diseases
Lancet Infect Dis; 2020 May; 20(5):511. PubMed ID: 32311325
[No Abstract] [Full Text] [Related]
7. Covid-19 vaccines: Should we allow human challenge studies to infect healthy volunteers with SARS-CoV-2?
McPartlin SO; Morrison J; Rohrig A; Weijer C
BMJ; 2020 Nov; 371():m4258. PubMed ID: 33168564
[No Abstract] [Full Text] [Related]
8. Dozens to be deliberately infected with coronavirus in UK 'human challenge' trials.
Callaway E
Nature; 2020 Oct; 586(7831):651-652. PubMed ID: 33082550
[No Abstract] [Full Text] [Related]
9. In the COVID-19 era, let's keep an eye on clinical trials in Africa.
Agoro R
J Glob Health; 2020 Dec; 10(2):020312. PubMed ID: 33110516
[No Abstract] [Full Text] [Related]
10. Current development of COVID-19 diagnostics, vaccines and therapeutics.
Zhang N; Li C; Hu Y; Li K; Liang J; Wang L; Du L; Jiang S
Microbes Infect; 2020; 22(6-7):231-235. PubMed ID: 32387332
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 controlled human infection models: Ethics, challenge agent production and regulatory issues.
Baay M; Neels P
Biologicals; 2020 Sep; 67():69-74. PubMed ID: 32829985
[TBL] [Abstract][Full Text] [Related]
12. Audio Interview: Covid-19 Vaccine Development.
Rubin EJ; Baden LR; Morrissey S
N Engl J Med; 2020 Jul; 383(3):e40. PubMed ID: 32668131
[No Abstract] [Full Text] [Related]
13. Ethical Considerations for COVID-19 Vaccine Trials in Correctional Facilities.
Wang EA; Zenilman J; Brinkley-Rubinstein L
JAMA; 2020 Sep; 324(11):1031-1032. PubMed ID: 32808972
[No Abstract] [Full Text] [Related]
14. Potential Challenges for Coronavirus (SARS-CoV-2) Vaccines Under Trial.
Usmani SS; Raghava GPS
Front Immunol; 2020; 11():561851. PubMed ID: 33133071
[No Abstract] [Full Text] [Related]
15. A vaccine is not too far for COVID-19.
Patel SK; Pathak M; Tiwari R; Yatoo MI; Malik YS; Sah R; Rabaan AA; Sharun K; Dhama K; Bonilla-Aldana DK; Rodriguez-Morales AJ
J Infect Dev Ctries; 2020 May; 14(5):450-453. PubMed ID: 32525830
[No Abstract] [Full Text] [Related]
16. COVID-19 disrupts vaccine delivery.
Nelson R
Lancet Infect Dis; 2020 May; 20(5):546. PubMed ID: 32311326
[No Abstract] [Full Text] [Related]
17. Covid-19: Human challenge studies will see people purposefully infected with virus.
Mahase E
BMJ; 2020 Oct; 371():m4101. PubMed ID: 33093016
[No Abstract] [Full Text] [Related]
18. COVID-19 drive through testing: An effective strategy for conserving personal protective equipment.
Ton AN; Jethwa T; Waters K; Speicher LL; Francis D
Am J Infect Control; 2020 Jun; 48(6):731-732. PubMed ID: 32305432
[No Abstract] [Full Text] [Related]
19. Tracking a Vaccine and Developing Therapeutics for COVID-19.
Gould KA
Dimens Crit Care Nurs; 2020; 39(6):293-297. PubMed ID: 33009266
[No Abstract] [Full Text] [Related]
20. COVID vaccination logistics: five steps to take now.
Teerawattananon Y; Dabak SV
Nature; 2020 Nov; 587(7833):194-196. PubMed ID: 33168970
[No Abstract] [Full Text] [Related]
[Next] [New Search]
